Automated Pharmaceutical Production Line

Revolutionizing drug manufacturing with cutting-edge automation and control systems

project details

Client: PharmaCorp Inc.
Project Start: 15/09/2024
Solution: Fully Automated Pharmaceutical Production Line
Client Website https://www.pharmacorprx.ca
Client Location: Regina, Canada
Value: $12,000,000
Other: FDA and EMA compliant systems

Brochure

Download our document to see specific data of the service and how we work.

BROCHURE.DOC
1.25M
BROCHURE.PDF
3.81M

Let’s Start Work
Together

Please feel free to contact us. We will get back to you with 1-2 business days. Or just call us now.

About Project

Synenco partnered with PharmaCorp, a leading pharmaceutical company, to design and implement a state-of-the-art automated production line for their new cancer drug manufacturing facility. This project aimed to optimize production processes, enhance quality control, and increase overall efficiency while maintaining strict regulatory compliance.


The scope included integrating advanced robotics, AI-driven quality control systems, and IoT sensors to create a seamless, data-driven manufacturing environment. Our team of industrial engineers and automation experts worked closely with PharmaCorp to develop custom solutions that addressed their unique challenges and goals.

Our Client’s Challenge

PharmaCorp faced increasing demand for their innovative cancer treatments while struggling with traditional manufacturing limitations. They needed to scale up production, reduce human error, and ensure consistent quality across batches. Additionally, they sought to improve energy efficiency and reduce waste in their manufacturing process to meet sustainability targets.

Our Approach And Solution

Synenco developed a comprehensive automation strategy that included:

Results

The $12 million project was completed in 18 months, with both phases delivered on schedule and under budget. The new automated production line increased output by 300% while reducing error rates by 99.9%. Energy consumption was cut by 40%, and waste reduction exceeded initial targets by 25%. PharmaCorp now leads the industry in manufacturing efficiency and quality control.